These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 31408410

  • 1. Bone mineral density and its influencing factors in children with idiopathic nephrotic syndrome: a prospective observational study.
    Sharawat IK, Dawman L, Kumkhaniya MV, Devpura K, Mehta A.
    Trop Doct; 2019 Oct; 49(4):292-298. PubMed ID: 31408410
    [Abstract] [Full Text] [Related]

  • 2. Bone mineral density and vitamin D status in children with remission phase of steroid-sensitive nephrotic syndrome.
    Cetin N, Gencler A, Sivrikoz IA.
    Saudi J Kidney Dis Transpl; 2019 Oct; 30(4):853-862. PubMed ID: 31464242
    [Abstract] [Full Text] [Related]

  • 3. Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease?
    Gulati S, Godbole M, Singh U, Gulati K, Srivastava A.
    Am J Kidney Dis; 2003 Jun; 41(6):1163-9. PubMed ID: 12776267
    [Abstract] [Full Text] [Related]

  • 4. Markers of bone metabolism in children with nephrotic syndrome treated with corticosteroids.
    Pańczyk-Tomaszewska M, Adamczuk D, Kisiel A, Skrzypczyk P, Przedlacki J, Górska E, Stelmaszczyk-Emmel A, Demkow U, Roszkowska-Blaim M.
    Adv Exp Med Biol; 2015 Jun; 840():21-8. PubMed ID: 25310960
    [Abstract] [Full Text] [Related]

  • 5. Three-monthly bolus vitamin D supplements (1000 vs 400 IU/day) for prevention of bone loss in children with difficult-to-treat nephrotic syndrome: a randomised clinical trial.
    Singh DN, Krishnamurthy S, Kamalanathan SK, Harichandrakumar KT, Sivamurukan P.
    Paediatr Int Child Health; 2018 Nov; 38(4):251-260. PubMed ID: 30092157
    [Abstract] [Full Text] [Related]

  • 6. Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements.
    Gulati S, Sharma RK, Gulati K, Singh U, Srivastava A.
    Nephrol Dial Transplant; 2005 Aug; 20(8):1598-603. PubMed ID: 15956073
    [Abstract] [Full Text] [Related]

  • 7. Effect of two prophylactic bolus vitamin D dosing regimens (1000 IU/day vs. 400 IU/day) on bone mineral content in new-onset and infrequently-relapsing nephrotic syndrome: a randomised clinical trial.
    Muske S, Krishnamurthy S, Kamalanathan SK, Rajappa M, Harichandrakumar KT, Sivamurukan P.
    Paediatr Int Child Health; 2018 Feb; 38(1):23-33. PubMed ID: 28466679
    [Abstract] [Full Text] [Related]

  • 8. Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy.
    Fujita T, Satomura A, Hidaka M, Ohsawa I, Endo M, Ohi H.
    Calcif Tissue Int; 2000 Mar; 66(3):195-9. PubMed ID: 10666494
    [Abstract] [Full Text] [Related]

  • 9. Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome.
    Bak M, Serdaroglu E, Guclu R.
    Pediatr Nephrol; 2006 Mar; 21(3):350-4. PubMed ID: 16382319
    [Abstract] [Full Text] [Related]

  • 10. The effect of vitamin D and calcium supplementation in pediatric steroid-sensitive nephrotic syndrome.
    Banerjee S, Basu S, Sen A, Sengupta J.
    Pediatr Nephrol; 2017 Nov; 32(11):2063-2070. PubMed ID: 28725977
    [Abstract] [Full Text] [Related]

  • 11. Calcium and vitamin D for osteoprotection in children with new-onset nephrotic syndrome treated with steroids: a prospective, randomized, controlled, interventional study.
    Choudhary S, Agarwal I, Seshadri MS.
    Pediatr Nephrol; 2014 Jun; 29(6):1025-32. PubMed ID: 24414607
    [Abstract] [Full Text] [Related]

  • 12. Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome.
    Aggarwal A, Yadav AK, Ramachandran R, Kumar V, Kumar V, Sachdeva N, Khandelwal N, Jha V.
    Nephrology (Carlton); 2016 Jun; 21(6):483-9. PubMed ID: 26428957
    [Abstract] [Full Text] [Related]

  • 13. Bone mineral density in children with steroid-sensitive nephrotic syndrome.
    Mishra OP, Meena SK, Singh SK, Prasad R, Mishra RN.
    Indian J Pediatr; 2009 Dec; 76(12):1237-9. PubMed ID: 19936659
    [Abstract] [Full Text] [Related]

  • 14. Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome.
    Leonard MB, Feldman HI, Shults J, Zemel BS, Foster BJ, Stallings VA.
    N Engl J Med; 2004 Aug 26; 351(9):868-75. PubMed ID: 15329424
    [Abstract] [Full Text] [Related]

  • 15. Bone mineral density in children with relapsing nephrotic syndrome: A hospital-based study.
    Jesmin T, Al Mamun A, Rahman MA, Santa SM, Huque SS, Begum A, Roy RR, Rahman MH, Uddin GM.
    Saudi J Kidney Dis Transpl; 2019 Aug 26; 30(6):1415-1422. PubMed ID: 31929289
    [Abstract] [Full Text] [Related]

  • 16. Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome.
    Phan V, Blydt-Hansen T, Feber J, Alos N, Arora S, Atkinson S, Bell L, Clarson C, Couch R, Cummings EA, Filler G, Grant RM, Grimmer J, Hebert D, Lentle B, Ma J, Matzinger M, Midgley J, Pinsk M, Rodd C, Shenouda N, Stein R, Stephure D, Taback S, Williams K, Rauch F, Siminoski K, Ward LM, Canadian STOPP Consortium.
    Osteoporos Int; 2014 Feb 26; 25(2):627-37. PubMed ID: 23948876
    [Abstract] [Full Text] [Related]

  • 17. Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome.
    Feber J, Gaboury I, Ni A, Alos N, Arora S, Bell L, Blydt-Hansen T, Clarson C, Filler G, Hay J, Hebert D, Lentle B, Matzinger M, Midgley J, Moher D, Pinsk M, Rauch F, Rodd C, Shenouda N, Siminoski K, Ward LM, Canadian STOPP Consortium.
    Osteoporos Int; 2012 Feb 26; 23(2):751-60. PubMed ID: 21494860
    [Abstract] [Full Text] [Related]

  • 18. Effect of glucocorticoids on growth and bone mineral density in children with nephrotic syndrome.
    Ribeiro D, Zawadynski S, Pittet LF, Chevalley T, Girardin E, Parvex P.
    Eur J Pediatr; 2015 Jul 26; 174(7):911-7. PubMed ID: 25573461
    [Abstract] [Full Text] [Related]

  • 19. Bone densitometry in children with idiopathic nephrotic syndrome on prolonged steroid therapy: A tertiary multicenter study.
    Soliman ASA, Abukhatwah MW, Kamal NM, Sweed EMM, Alelyani AM, Althobaiti SD, Alzaedi MA, El-Rebigi AM, Besher NT, Abukhatwah OMW, Alharbi AO, Afifi WE.
    Medicine (Baltimore); 2022 Aug 19; 101(33):e29860. PubMed ID: 35984137
    [Abstract] [Full Text] [Related]

  • 20. Divergent effects of glucocorticoids on cortical and trabecular compartment BMD in childhood nephrotic syndrome.
    Wetzsteon RJ, Shults J, Zemel BS, Gupta PU, Burnham JM, Herskovitz RM, Howard KM, Leonard MB.
    J Bone Miner Res; 2009 Mar 19; 24(3):503-13. PubMed ID: 19016583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.